Skip to content

Clinical trials

Phase 2 Lymphoma, Non-Hodgkin trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 2 Country / region: Japan Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20071
20101
20181
20191
20202
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
SymBio Pharmaceuticals2
AstraZeneca1
Bayer1
Genmab1
Genzyme, a Sanofi Company1
Incyte Corporation1
Keio University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin11
Lymphoma, B-Cell4
Lymphoma, Follicular4
Recurrence4
Lymphoma, Large B-Cell, Diffuse3
Lymphoma2
Lymphoma, Mantle-Cell2
Burkitt Lymphoma1
Dendritic Cell Sarcoma, Interdigitating1
Leukemia, Hairy Cell1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.